A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria
- PMID: 23354369
- PMCID: PMC3580031
- DOI: 10.1097/IGC.0b013e318280f395
A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria
Abstract
Objective: Cervical cancer is the most common gynecological cancer in developing countries. Visual inspection with acetic acid (VIA) was introduced to screen for cervical premalignant lesions in developing countries owing to the inability of many countries to implement high-quality cytologic services. We sought to compare VIA performance among different health workers in Nigeria.
Methods: In a population-based project, 7 health workers who had been screening women with VIA for approximately 2 years at local government health centers in rural Nigeria were retrained in a 2-week program using the International Agency for Research on Cancer training manual. Women from a rural village who had never had cervical cancer screening were recruited into the study. Each woman had cervical cancer screening by VIA, liquid-based cytologic test, and oncogenic human papillomavirus (HPV) DNA test.
Results: Despite similar participant characteristics, across all age groups, providers had wide ranges of VIA results; 0% to 21% suspect cancer and 0% to 25% were VIA positive. Visual inspection with acetic acid was insensitive compared to a combination of cytologic and HPV tests.
Conclusion: In our study, VIA was not reproducible, nor was it sensitive compared to cytologic and HPV tests.
Figures

Similar articles
-
Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.Int J Gynecol Cancer. 2013 Mar;23(3):513-8. doi: 10.1097/IGC.0b013e318280f3bc. Int J Gynecol Cancer. 2013. PMID: 23334437
-
Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.PLoS One. 2016 Jan 5;11(1):e0144905. doi: 10.1371/journal.pone.0144905. eCollection 2016. PLoS One. 2016. PMID: 26730710 Free PMC article.
-
[Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].Rev Epidemiol Sante Publique. 2019 Apr;67(2):120-125. doi: 10.1016/j.respe.2018.10.003. Epub 2018 Nov 14. Rev Epidemiol Sante Publique. 2019. PMID: 30448093 French.
-
[Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].Epidemiol Prev. 2012 Mar-Apr;36(2):108-19. Epidemiol Prev. 2012. PMID: 22706361 Review. Italian.
-
Cervical cancer in low-income countries: A Bangladeshi perspective.Int J Gynaecol Obstet. 2021 Jan;152(1):19-25. doi: 10.1002/ijgo.13400. Epub 2020 Oct 17. Int J Gynaecol Obstet. 2021. PMID: 32989750 Review.
Cited by
-
The Future of Cervical Cancer Screening.Int J Womens Health. 2024 Oct 23;16:1715-1731. doi: 10.2147/IJWH.S474571. eCollection 2024. Int J Womens Health. 2024. PMID: 39464249 Free PMC article. Review.
-
False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.Diagnostics (Basel). 2022 Jun 20;12(6):1508. doi: 10.3390/diagnostics12061508. Diagnostics (Basel). 2022. PMID: 35741319 Free PMC article. Review.
-
Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.PLoS One. 2021 Dec 16;16(12):e0260776. doi: 10.1371/journal.pone.0260776. eCollection 2021. PLoS One. 2021. PMID: 34914727 Free PMC article.
-
The Predictors for Non-Adherence to Colposcopy among Women in an Underserved Community in Rural Southern Western Nigeria.Niger Med J. 2022 Sep 10;63(1):22-28. doi: 10.60787/NMJ-63-1-121. eCollection 2022 Jan-Feb. Niger Med J. 2022. PMID: 38798963 Free PMC article.
-
Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5. BMC Cancer. 2017. PMID: 29121873 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: The size of the problem. Best Pract & Res Clin Obstet Gynaecol. 2006;20:207–222. - PubMed
-
- Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29. - PubMed
-
- Chokunonga E, Levy LM, Basset MT, et al. Cancer incidence in the African population of Harare, Zimbabwe: Second results from the Cancer: Registry 1993–1995. Int J Cancer. 2000;85:54–55. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical